[{"Assets_0_Q2_USD":301877000.0,"CommonStockSharesOutstanding_0_Q2_shares":43115738.0,"NetIncomeLoss_2_Q2_USD":-47215000.0,"NetIncomeLoss_1_Q2_USD":-23883000.0,"StockholdersEquity_0_Q2_USD":281710000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]